Kuznetsova T, Prange KHM, Glass CK, de Winther MPJ. Nat Rev Cardiol. 2019 Oct 2.PMID: 31578516
Dysregulated macrophages are major drivers in cardio-metabolic diseases where local and systemic cues impact on the transcriptional programs of macrophages and their precursors, monocytes. In this review, the current understanding of the transcriptional and epigenetic regulation of monocytes and macrophages in relation to atherosclerotic disease is discussed, as is our increasing knowledge on the potential to interfere with these processes as therapeutic interventions.
Our mission: To reduce the burden of cardiovascular disease.